Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by hypergonadotropic hypogonadism, intellectual deficit, congenital skeletal anomalies involving the cervical spine and superior ribs, and diabetes mellitus.
Biomarker and diagnostic research for male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome.
11 publications have been identified in PubMed for male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome. Research spans Case Report / Case Series (55%), Review / Meta-Analysis (27%), and Diagnostic / Biomarker (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 55% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:51 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
3 |
27% |
Testing and diagnosis research | 1 | 9% |
Disease patterns and progression | 1 | 9% |
Lamb DJ (2026). [PMID: 41486877](https://pubmed.ncbi.nlm.nih.gov/41486877/). *Endocrinology*. [Review / Meta-Analysis]
Rohayem J (2026). [PMID: 40297921](https://pubmed.ncbi.nlm.nih.gov/40297921/). *Andrology*. [Epidemiology / Natural History]
Ünsal Y (2026). [PMID: 39975416](https://pubmed.ncbi.nlm.nih.gov/39975416/). *J Clin Res Pediatr Endocrinol*. [Review / Meta-Analysis]
Saadati F (2026). [PMID: 42083509](https://pubmed.ncbi.nlm.nih.gov/42083509/). *Andrology*. [Review / Meta-Analysis]
Zeng W (2026). [PMID: 42108647](https://pubmed.ncbi.nlm.nih.gov/42108647/). *Am J Case Rep*. [Case Report / Case Series]
Oktay MA (2026). [PMID: 42112678](https://pubmed.ncbi.nlm.nih.gov/42112678/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Shibahara J (2025). [PMID: 41320308](https://pubmed.ncbi.nlm.nih.gov/41320308/). *J UOEH*. [Case Report / Case Series]
Shrestha A (2025). [PMID: 40018421](https://pubmed.ncbi.nlm.nih.gov/40018421/). *Clin Case Rep*. [Case Report / Case Series]
Ghatanatti J (2025). [PMID: 39944420](https://pubmed.ncbi.nlm.nih.gov/39944420/). *Cureus*. [Case Report / Case Series]
Akalın A (2025). [PMID: 40211555](https://pubmed.ncbi.nlm.nih.gov/40211555/). *J Clin Res Pediatr Endocrinol*. [Diagnostic / Biomarker]